相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy
Mattias Mandorfer et al.
HEPATOLOGY (2020)
Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding
Andrew M. Moon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals
Monica Pons et al.
JOURNAL OF HEPATOLOGY (2020)
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis
Scott A. McDonald et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient
Mattias Mandorfer et al.
LIVER INTERNATIONAL (2020)
The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis
Remy Schwarzer et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy
Dominique Thabut et al.
GASTROENTEROLOGY (2019)
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Candid Villanueva et al.
LANCET (2019)
Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
Alastair Heffernan et al.
LANCET (2019)
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis
Fanpu Ji et al.
JOURNAL OF HEPATOLOGY (2019)
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity
M. Mandorfer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome
Felix Piecha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals
Francesco Paolo Russo et al.
LIVER INTERNATIONAL (2018)
S3-Guideline Prophylaxis, Diagnosis and Treatment of Hepatitis-C-Virus (HCV) Infection
Christoph Sarrazin et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2018)
von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C
Hiroaki Takaya et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
P. Schwabl et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
Sabela Lens et al.
GASTROENTEROLOGY (2017)
EASL Recommendations on Treatment of Hepatitis C 2016
JOURNAL OF HEPATOLOGY (2017)
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension
N. Afdhal et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Beta blockers and cirrhosis, 2016
Mattias Mandorfer et al.
DIGESTIVE AND LIVER DISEASE (2017)
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
Mattias Mandorfer et al.
JOURNAL OF HEPATOLOGY (2016)
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses
M. Mandorfer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
Roberto de Franchis
JOURNAL OF HEPATOLOGY (2015)
EASL Recommendations on Treatment of Hepatitis C 2015
JOURNAL OF HEPATOLOGY (2015)
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C
A. Maieron et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis
Monika Ferlitsch et al.
HEPATOLOGY (2012)
Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
Vincenzo La Mura et al.
GUT (2011)
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
Cristina Ripoll et al.
JOURNAL OF HEPATOLOGY (2009)
Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease
C. Bureau et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis
Francesco Vizzutti et al.
HEPATOLOGY (2007)
分享论文
